Israel Active

Israeli startup iNNOGING enables physicians to manipulate ultrasound video captured previously by a technician and perform a virtual dynamic exam without the patient being present. The original scan’s video clips are converted into a 3D model of the examined area.

Zen Eating, with R&D in Israel, has developed the Sipper – a device that trains the tongue to digest food slower, to match the brain’s “I’m full” mechanism. A Sipper user eats up to 30% less food per meal. The training also can cure snoring – a major cause of sleep apnea.

Volunteers from Israel’s ZAKA Search & Rescue, Dream Doctors and the Psycho-trauma and Crisis Response Unit of Israel’s United Hatzalah have arrived in Pittsburgh to provide aid to the community and the victims of the deadly mass shooting at the Tree of Life synagogue.

Israel’s Sheba Medical Center hosted a summit “The Future Hospital: Setting Strategies for 2030 and Beyond”. Healthcare leaders and innovators from the USA, Canada, UK, EU and Israel discussed challenges facing hospitals and saw Israeli cutting-edge technologies shaping the future of medicine.

I reported previously about Israel’s Clew Medical and its system to warn of deteriorating Intensive Care Unit (ICU) patients. It has since been trialed at Tel Aviv’s Sourasky (Ichilov) Hospital and several US hospitals and is to be used at Tel Hashomer’s Sheba Medical Center.

I reported previously that Israel’s Regentis was to begin Phase III trials on its GelrinC, treatment for cartilage damage in the knee. The study has now been extended to 11 US sites involving 120 patients. The GelrinC implant encourages stem cells to re-grow cartilage.

Israel’s CollPlant has licensed US’s United Therapeutics to use CollPlant’s 3D bio-printing technology to manufacture lung transplants. The multi-million-dollar agreement can be expanded to print up to three additional organs. CollPlant will initially supply the necessary bio-ink

I reported previously that Israel’s UroGen Pharma had been granted FDA’s Orphan status for its treatment of malignant Upper Tract Urothelial Carcinoma. It has now received Breakthrough Therapy Designation status to help speed up development.

Israeli biotech Cellect is developing stem cell technology that may extend individual human life far beyond what currently can be conceived.  And a new international study forecasts Israeli life-expectancy to rise to 84.4 by 2040, giving Israel a world ranking of 7 (currently 13).

Researchers at Ben-Gurion University have identified certain proteins in the human body that are key to progressing or preventing diseases such as cancer. They have mapped protein to protein interactions and are confident they can develop new treatments for those diseases.